Shadow AI is already moving supplier specs, formulations, and traceability records off your control. What it means for FSMA ...

Boehringer Ingelheim’s Hernexeos has nabbed a companion diagnostic from Guardant Health after the FDA cleared its liquid biopsy test, Guardant360 CDx. Hernexeos was approved last August for previously ...

A record-high number of Americans say they disapprove of President Donald Trump’s time in the White House, according to the latest Economist/YouGov poll. The poll, released June 2, showed that about ...

As of June 1, 2026, major polling groups show President Donald Trump’s approval rating is hovering between 34% and 40% in his second term. This means roughly four out of 10 Americans believe he is ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. President Donald Trump’s approval ratings have fallen to new lows ...

On Thursday the White House released long-anticipated draft regulations that, if enacted, would give political appointees the final word on federal research grants and other funding across government ...

A clear majority of President Donald Trump’s 2024 voters continue to approve of the job he is doing in office, but his rating has declined among this group and the public as a whole – and his standing ...

Bitcoin’s dip below $76,000 was driven by an AI sector sell-off and investors’ worries about slowed progress in the CLARITY Act negotiations. Stalled progress on the CLARITY Act and hiccups in AI ...

The CNBC All-America Economic survey showed 40% of people nationwide approve of the President Donald Trump's overall job performance. Trump's net approval rating fell 10 points to -18, the lowest ever ...

President Donald Trump’s job approval rating has sunk to a new low as Americans express growing concerns about rising costs and the war with Iran, according to an NBC News Decision Desk Poll powered ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. President Donald Trump’s approval rating among independent voters has ...

Many of the bispecific antibodies (BsAbs) approved by global regulators have yet to demonstrate robust clinical benefit beyond surrogate endpoints that led to their initial approval, according to ...